These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 20962858)
21. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects. Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614 [TBL] [Abstract][Full Text] [Related]
22. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Kampus P; Muda P; Kals J; Ristimäe T; Fischer K; Teesalu R; Zilmer M Int J Cardiol; 2006 Sep; 112(1):46-51. PubMed ID: 16297996 [TBL] [Abstract][Full Text] [Related]
23. Correlation between high sensitive C-reactive protein and aortic stiffness using magnetic resonance imaging in patients with known/suspected coronary artery disease. Srirattana P; Boonyasirinant T J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S105-10. PubMed ID: 22574538 [TBL] [Abstract][Full Text] [Related]
24. Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension. Tsioufis C; Stougiannos P; Kakkavas A; Toutouza M; Mariolis A; Vlasseros I; Stefanadis C; Kallikazaros I Am J Cardiol; 2005 Jul; 96(2):252-6. PubMed ID: 16018852 [TBL] [Abstract][Full Text] [Related]
25. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Yasmin ; McEniery CM; Wallace S; Mackenzie IS; Cockcroft JR; Wilkinson IB Arterioscler Thromb Vasc Biol; 2004 May; 24(5):969-74. PubMed ID: 15001456 [TBL] [Abstract][Full Text] [Related]
26. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662 [TBL] [Abstract][Full Text] [Related]
27. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928 [TBL] [Abstract][Full Text] [Related]
28. Association of serum lipids with arterial stiffness in a population-based study in Beijing. Wang F; Ye P; Luo L; Xiao W; Qi L; Bian S; Wu H; Sheng L; Xiao T; Xu R Eur J Clin Invest; 2011 Sep; 41(9):929-36. PubMed ID: 21314825 [TBL] [Abstract][Full Text] [Related]
30. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. Cicero AF; Salvi P; D'Addato S; Rosticci M; Borghi C; J Hypertens; 2014 Jan; 32(1):57-64. PubMed ID: 24309486 [TBL] [Abstract][Full Text] [Related]
31. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Kullo IJ; Seward JB; Bailey KR; Bielak LF; Grossardt BR; Sheedy PF; Peyser PA; Turner ST Am J Hypertens; 2005 Aug; 18(8):1123-9. PubMed ID: 16109328 [TBL] [Abstract][Full Text] [Related]
32. Soluble receptor for advanced glycation end-product levels are related to albuminuria and arterial stiffness in essential hypertension. Dimitriadis K; Tsioufis C; Kasiakogias A; Miliou A; Poulakis M; Kintis K; Bafakis I; Benardis E; Tousoulis D; Stefanadis C Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):382-8. PubMed ID: 22212601 [TBL] [Abstract][Full Text] [Related]
33. The relationship between osteopontin and adiponectin in patients with essential hypertension. Kurata M; Okura T; Irita J; Enomoto D; Nagao T; Jotoku M; Miyoshi K; Higaki J Clin Exp Hypertens; 2010; 32(6):358-63. PubMed ID: 21028999 [TBL] [Abstract][Full Text] [Related]
34. High-sensitivity C-reactive protein and total antioxidant status in patients with essential arterial hypertension and dyslipidemia. Kuklinska AM; Mroczko B; Musial WJ; Sawicki R; Kozieradzka A; Waszkiewicz E; Szmitkowski M Adv Med Sci; 2009; 54(2):225-32. PubMed ID: 20053618 [TBL] [Abstract][Full Text] [Related]
35. Serum uric acid and hemorheology in borderline hypertensives and in subjects with established hypertension and left ventricular hypertrophy. Höieggen A; Fossum E; Reims H; Kjeldsen SE Blood Press; 2003; 12(2):104-10. PubMed ID: 12797630 [TBL] [Abstract][Full Text] [Related]
36. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects. Cicero AF; Rosticci M; Fogacci F; Grandi E; D'Addato S; Borghi C; Eur J Intern Med; 2017 Jan; 37():38-42. PubMed ID: 27498274 [TBL] [Abstract][Full Text] [Related]
37. IL-18 is involved in vascular injury in end-stage renal disease patients. Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894 [TBL] [Abstract][Full Text] [Related]
38. Relationships of C-reactive protein, uric acid, and glomerular filtration rate to arterial stiffness in Japanese subjects. Saijo Y; Utsugi M; Yoshioka E; Horikawa N; Sato T; Gong YY; Kishi R J Hum Hypertens; 2005 Nov; 19(11):907-13. PubMed ID: 16079884 [TBL] [Abstract][Full Text] [Related]
39. Markers of systemic inflammation in children with hyperuricemia. Wasilewska A; Tenderenda E; Taranta-Janusz K; Tobolczyk J; Stypułkowska J Acta Paediatr; 2012 May; 101(5):497-500. PubMed ID: 22211844 [TBL] [Abstract][Full Text] [Related]